Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives

J Enzyme Inhib Med Chem. 2017 Dec;32(1):746-758. doi: 10.1080/14756366.2017.1316494.

Abstract

We designed and synthesised novel N-substituted 1,3-thiazolidin-4-one derivatives for the evaluation of their anti-Toxoplasma gondii efficacy. This scaffold was functionalised both at the N1-hydrazine portion with three structurally different moieties and at the lactam nitrogen with substituted benzyl groups selected on the basis of our previous structure-activity relationships studies. Using three different assay methods, the compounds were assessed in vitro to determine both the levels of efficacy against the tachyzoites of T. gondii (IC50 = 5-148 μM), as well as any evidence of cytotoxicity towards human host cells (TD50 = 68 to ≥320 μM). Results revealed that ferrocene-based thiazolidinones can possess potent anti-tachyzoite activity (TI =2-64).

Keywords: 1,3-thiazolidin-4-one; Toxoplasma; cytotoxicity; ferrocene; host cell invasion; parasite growth inhibition.

MeSH terms

  • Antiprotozoal Agents / chemical synthesis
  • Antiprotozoal Agents / chemistry
  • Antiprotozoal Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Molecular Structure
  • Parasitic Sensitivity Tests
  • Structure-Activity Relationship
  • Thiazolidines / chemical synthesis
  • Thiazolidines / chemistry
  • Thiazolidines / pharmacology*
  • Toxoplasma / drug effects*
  • Toxoplasma / growth & development

Substances

  • Antiprotozoal Agents
  • Thiazolidines

Grants and funding

This work was supported by FILAS (research project n° ASR2, Regione Lazio, Italy) and the Stanley Medical Research Institute (LJ-B).